Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
(2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid
Unique ID
C000719109
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000719109
Entry Term(s)
(2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride
EP-7041
EP-7041 HCl
EP-7041 hydrochloride
Registry Numbers
0
Heading Mapped to
*Aminopyridines
*Lactams
*Urea
Frequency
0
Note
factor XIa inhibitor
Source
Crit Care Explor. 2020 Sep 15;2(9):e0196.
Date of Entry
2021/09/14
Revision Date
2021/09/14
(2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid Preferred
EP-7041 Narrower
(2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride Narrower
page delivered in 0.006s